8.98
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EVH Giù?
Forum
Previsione
Evolent Health Inc Borsa (EVH) Ultime notizie
Evolent Health Nominates Shawn Guertin to Board - TipRanks
Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors | EVH Stock News - GuruFocus
Evolent Names Shawn Guertin As New Independent Nominee For Election To Its Board Of Directors - marketscreener.com
Healthcare Finance Veteran Shawn Guertin Brings 40-Year Experience to Evolent Board Nomination - Stock Titan
Molina Healthcare, Encompass Health, RadNet, Evolent Health, and Ibotta Shares Are Falling, What You Need To Know - Yahoo Finance
Analysts’ Top Healthcare Picks: Evolent Health (EVH), Gilead Sciences (GILD) - The Globe and Mail
Evolent Health Insiders Placed Bullish Bets Worth US$1.35m - Yahoo
Evolent program achieves 20% reduction in use of low-value oncol - GuruFocus
Evolent program achieves 20% reduction in use of low-value oncology regimens - PR Newswire
Healthcare Breakthrough: Evolent Slashes Expensive Cancer Treatment Costs While Maintaining Care Quality - Stock Titan
Benign Growth For Evolent Health, Inc. (NYSE:EVH) Underpins Its Share Price - simplywall.st
Evolent To Release First Quarter 2025 Financial Results on Thurs - GuruFocus
Evolent Health (EVH) Price Target Lowered by Truist Analyst Amid Market Uncertainty | EVH Stock News - GuruFocus
Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025 - The Malaysian Reserve
The Analyst Verdict: Evolent Health In The Eyes Of 16 Experts - Benzinga
1 Growth Stock to Stash and 2 to Keep Off Your Radar - The Globe and Mail
Evolent Health price target lowered to $14 from $15 at Truist - TipRanks
Truist Cuts Price Target on Evolent Health to $14 From $15, Keeps Buy Rating - marketscreener.com
Indo-Asian News Service - Indo-Asian News Service (IANS)
Evolent Health Sets Q1 Earnings Date: Key Financial Results and Conference Details Ahead - Stock Titan
Evolent Health, Inc. (NYSE:EVH) Receives $17.71 Consensus Target Price from Brokerages - MarketBeat
KeyBanc sees PRVA acquisition of EVH’s MSSP as unlikely but instructive - Investing.com Australia
Evolent Health, Inc. (EVH): Among Stocks Insiders Were Buying In Q1 2025 - Yahoo
20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey
Is Evolent Health (EVH) About to Explode? - Insider Monkey
12 Stocks That Are About to Explode - Insider Monkey
Here’s What Challenged Evolent Health (EVH) Despite Strong Revenue Growth - Insider Monkey
Evolent Health (NYSE:EVH) shareholders have endured a 69% loss from investing in the stock a year ago - Yahoo Finance
When the Price of (EVH) Talks, People Listen - Stock Traders Daily
1 Healthcare Stock on Our Watchlist and 2 to Turn Down - The Globe and Mail
Evolent Health (EVH): Among Stocks Insiders Are Buying In March - Insider Monkey
Evolent Health Co-Founder Acquires 13% More Stock - simplywall.st
10 Stocks Insiders Are Buying In March - Insider Monkey
Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR) - The Globe and Mail
Cardinal Health Adds Two Members to Its Board of Directors - HME Business
Commit To Buy Evolent Health At $7.50, Earn 22.1% Annualized Using Options - Nasdaq
Define Ventures Appoints Carolyn Magill as Venture Partner - Quantisnow
Healthcare Powerhouse Carolyn Magill Joins $800M Define Ventures Leadership Team - StockTitan
Evolent Health (NYSE:EVH) Given New $12.00 Price Target at JPMorgan Chase & Co. - Defense World
Evolent Health, Inc. (NYSE:EVH) Receives Average Rating of “Buy” from Analysts - Defense World
Evolent health director Brendan Springstubb acquires $139,050 in stock By Investing.com - Investing.com South Africa
Evolent Health director Keck Kim buys $99,497 in stock By Investing.com - Investing.com South Africa
Evolent Health director Glass Russell Monroe acquires $50,058 in stock By Investing.com - Investing.com South Africa
Beyond The Numbers: 18 Analysts Discuss Evolent Health Stock - Benzinga
Evolent health director Peter Grua acquires $99,470 in shares By Investing.com - Investing.com Australia
Evolent Health CEO Seth Blackley purchases $497,577 in stock By Investing.com - Investing.com South Africa
Evolent Health president Daniel McCarthy buys $99,470 in stock By Investing.com - Investing.com Canada
Evolent health director Diane Holder buys shares worth $25,517 By Investing.com - Investing.com South Africa
Evolent Health director Glass Russell Monroe acquires $50,058 in stock - Investing.com
Evolent Health director Craig Barbarosh buys $17,620 in stock By Investing.com - Investing.com South Africa
Evolent Health president Daniel McCarthy buys $99,470 in stock - Investing.com India
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):